ITGAM and cancer: Systemic expansion of immature myeloid cells during cancer progression can be divided into two subpopulations of granulocytic (CD11b+/Ly6G+) and monocytic (CD11b+/Ly6Chi) myeloid-derived suppressor cells (9).